Genomics BioSci & Tech, Taiwan’s largest commercial genomic sequencing company, is leveraging artificial intelligence (AI) to decode the secrets of aging and disease. Company founder and chairman Joseph Chow emphasized that each genome is a unique code containing the mysteries of life and death, with breakthroughs in identifying key genes potentially enabling “immortality.” AI integration promises transformative progress in this field.
Genomics BioSci & Tech bets on AI to unlock gene-based longevity
16
Apr